Dr. Siddharth Kaul, MD
Claim this profileClinical Research Professionals
Studies Alzheimer's Disease
Studies Cognitive Impairment
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Siddharth Kaul, MD is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
GSK4527226
for Early Alzheimer's Disease
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (including mild cognitive impairment \[MCI\] and mild dementia due to AD) of 2 dose levels of GSK4527226 compared to placebo.
Recruiting0 awards Phase 214 criteria
More about Siddharth Kaul, MD
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Siddharth Kaul, MD has experience with
- Donanemab
- Placebo
- Simufilam
- Aducanumab
- Remternetug (IV)
- Remternetug (SC)
Breakdown of trials Siddharth Kaul, MD has run
Alzheimer's Disease
Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Siddharth Kaul, MD specialize in?
Siddharth Kaul, MD focuses on Alzheimer's Disease and Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved APOE patients, or patients who are undergoing treatment.
Is Siddharth Kaul, MD currently recruiting for clinical trials?
Yes, Siddharth Kaul, MD is currently recruiting for 3 clinical trials in Chesterfield Missouri. If you're interested in participating, you should apply.
Are there any treatments that Siddharth Kaul, MD has studied deeply?
Yes, Siddharth Kaul, MD has studied treatments such as Donanemab, Placebo, Simufilam.
What is the best way to schedule an appointment with Siddharth Kaul, MD?
Apply for one of the trials that Siddharth Kaul, MD is conducting.
What is the office address of Siddharth Kaul, MD?
The office of Siddharth Kaul, MD is located at: Clinical Research Professionals, Chesterfield, Missouri 63005 United States. This is the address for their practice at the Clinical Research Professionals.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.